ArticleScientific reports2025
Meta simulation approach for evaluating machine learning method selection in data limited settings.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leveraging mRNA cMH and machine learning for the deconvolution of mixed body fluid stains in East Asian populations.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selecting appropriate machine learning (ML) methods for domain-specific tasks remains a persistent challenge, particularly in medicine where datasets are often small, heterogeneous, and incomplete. Traditional benchmarking strategies rely on limited observational samples, which may not capture the complexity of the underlying data-generating process (DGP). As a result, methods that perform well on available data may generalise poorly in real-world practice. We present SimCalibration, a meta-simulation framework that leverages structural learners (SLs) to infer an approximated data-generating process from limited data and generate synthetic datasets for large-scale benchmarking. This framework enables systematic evaluation of machine learning method selection strategies in settings where the true data-generating process is either known or can be approximated, allowing both validation against the ground truth and the generation of synthetic observations inferred from sparse samples. In rare disease research for example, where patient cohorts are inherently small, causal relationships are often conceptualised as directed acyclic graphs (DAGs). In this work, such structures are approximated directly from observational data, extending the utility of small datasets by enabling investigators to benchmark ML methods in a controlled simulation setting before deploying them in practice. This reduces the risk of selecting models that generalise poorly and supports more reliable decision-making in sensitive healthcare contexts. Experiments demonstrate that (a) structural learners vary in their ability to recover representative simulations for benchmarking, (b) structural learner-based benchmarking reduces variance in performance estimates compared to traditional validation, and (c) in some cases, structural learner-based approaches yield rankings that more closely match true relative performance than those derived from limited datasets. These findings highlight the value of simulation-based benchmarking for domains where drawing generalisable conclusions is critical, such as medicine, and offer greater transparency into the assumptions underlying predictive decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.